Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, 2017, by 10.00 A.M.
Navigation
Announcements
Board Meeting-Outcome
Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members wherever necessary:
(i) To reappoint Dr. A. Velumani as Managing Director & CEO for 3 years from 01-04-2017 on a token salary of Re. 1/- per month as chosen by him.
(ii) To reappoint Mr. A. Sundararaju as Executive Director & CFO for 3 years from 01-04-2017 on the same salary of Rs. 5 lakhs per month.
(iii) To acquire the trademark “Whaters” from Dr. A. Velumani, Chairman & Managing Director, who offered to assign the same to the Company for a token consideration of Re. 1/- and the trademark “Nueclear” to NHL, the wholly owned subsidiary, for a similar token consideration of Re. 1/-, and also waive the royalty due to him from both the companies for usage till now.
(iv) To give loan to NHL, the wholly owned subsidiary, at arm’s length basis, to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc. for setting up additional scanning centres.
Investor/Analyst Meeting
Intimation about meeting of Mr. Owens Huang, Asia Specialist & Co-Portfolio Manager from Dalton Investment, US, with our Vice-President (Operations), Dr. Caesar Sengupta, and General Manager-Finance, Mr. Sachin Salvi, at our Corporate Office, on Tuesday, February 28, 2017 by 03.00 P.M.
Investor/Analyst Meeting
Intimation about meeting of Mr. Dushyant Sahani, Associate, of Samena Capital Investments Limited, Dubai, with our Vice President (Operations) Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, on Tuesday, February 21, 2017 by 03.00 PM and a likely meeting with our Chairman & Managing Director, Dr. A. Velumani too, subject to his availability.
Investor/Analyst Meeting
Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General Manager-Finance, Mr.Sachin Salvi and the Marketing Team at our Corporate Office, on Wednesday, February 15, 2017 by 11.00 AM, and a likely visit to one of our franchisees thereafter.
Board Meeting-Outcome
Intimation of Outcome of the Board Meeting held on January 28, 2017 .(i) To declare an interim dividend of Rs. 5/- per share and fixing of 09-02-2017 as record date for payment of dividend and (ii) To approve the unaudited financial results (Stand alone and Consolidated) for the quarter / nine months ended December 31, 2016.
Investor/Analyst Meeting
Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Arindam Bhattacharjee, Partner & Portfolio Manager, Mr. Paul Ballantyne, Partner & Portfolio Manager, and Mr. Sebastian Peters, Portfolio Manager of Genesis Investment Management Ltd., UK, at our office, by 9.00 A.M. on 13-12-2016.
Investor/Analyst Meeting
Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani at the IDFC Annual Investor Conference at “The Taj Lands End”, Mumbai, on 16-11-2016 where he would talk briefly about the Company, its nature of business and growth, and would also meet various investors / analysts attending the conference.